Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Cocrystal Pharma Q2 EPS $(0.50) Beats $(0.58) Estimate

Author: Happy Mohamed | August 14, 2023 08:46am

Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.58) by 13.79 percent. This is a 4.17 percent decrease over losses of $(0.48) per share from the same period last year.

Posted In: COCP


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist